National Advisory Council on Migrant Health; Cancellation of Meeting, 70788 [2012-28699]
Download as PDF
<![CDATA[
70788
Federal Register / Vol. 77, No. 228 / Tuesday, November 27, 2012 / Notices
wreier-aviles on DSK5TPTVN1PROD with
tracking quality improvement over time
(for example, measure selection criteria,
data collection and reporting
requirements)? What strategies
(including those related to health
information technology) could mitigate
these challenges?
3. Describe current public reporting or
transparency efforts that states and
private entities use to display health
care quality information.
4. How do health insurance issuers
currently monitor the performance of
hospitals and other providers with
which they have relationships? Do
health insurance issuers monitor patient
safety statistics, such as hospital
acquired conditions and mortality
outcomes, and if so, how? Do health
insurance issuers monitor care
coordination activities, such as hospital
discharge planning activities, and
outcomes of care coordination activities,
and if so, how?
Applicability to the Health Insurance
Exchange Marketplace
5. What opportunities exist to further
the goals of the National Quality
Strategy through quality reporting
requirements in the Exchange
marketplace?
6. What quality measures or measure
sets currently required or recognized by
states, accrediting entities, or CMS are
most relevant to the Exchange
marketplace?
7. Are there any gaps in current
clinical measure sets that may create
challenges for capturing experience in
the Exchange?
8. What are some issues to consider in
establishing requirements for an issuer’s
quality improvement strategy? How
might an Exchange evaluate the
effectiveness of quality improvement
strategies across plans and issuers?
What is the value in narrative reports to
assess quality improvement strategies?
9. What methods should be used to
capture and display quality
improvement activities? Which publicly
and privately funded activities to
promote data collection and
transparency could be leveraged (for
example, Meaningful Use Incentive
Program) to inform these methods?
10. What are the priority areas for the
quality rating in the Exchange
marketplace? (for example, delivery of
specific preventive services, health plan
performance and customer service)?
Should these be similar to or different
from the Medicare Advantage five-star
quality rating system (for example,
staying healthy: screenings, tests and
vaccines; managing chronic (long-term)
conditions; ratings of health plan
responsiveness and care; health plan
VerDate Mar<15>2010
15:05 Nov 26, 2012
Jkt 229001
members’ complaints and appeals; and
health plan telephone customer
service)? 3
11. What are effective ways to display
quality ratings that would be
meaningful for Exchange consumers and
small employers, especially drawing on
lessons learned from public reporting
and transparency efforts that states and
private entities use to display health
care quality information?
12. What types of methodological
challenges may exist with public
reporting of quality data in an
Exchange? What suggested strategies
would facilitate addressing these issues?
13. Describe any strategies that states
are considering to align quality
reporting requirements inside and
outside the Exchange marketplace, such
as creating a quality rating for
commercial plans offered in the nonExchange individual market.
14. Are there methods or strategies
that should be used to track the quality,
impact and performance of services for
those with accessibility and
communication barriers, such as
persons with disabilities or limited
English proficiency?
15. What factors should HHS consider
in designing an approach to calculate
health plan value that would be
meaningful to consumers? What are
potential benefits and limitations of
these factors? How should Exchanges
align their programs with value-based
purchasing and other new payment
models (for example, Accountable Care
Organizations) being implemented by
payers?
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: November 6, 2012.
Marilyn Tavenner,
Acting Administrator, Centers for Medicare
& Medicaid Services.
Approved: November 16, 2012.
Kathleen Sebelius,
Secretary.
AGENCY:
[FR Doc. 2012–28473 Filed 11–23–12; 11:15 am]
BILLING CODE 4120–01–P
3 For more information on Medicare Advantage
rating system domains see https://www.cms.gov/
Medicare/Health-Plans/HealthPlansGenInfo/
Downloads/2013-Call-Letter.pdf; https://
www.cms.gov/Medicare/Prescription-DrugCoverage/PrescriptionDrugCovGenIn/
PerformanceData.html.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Health Resources and Services
Administration
National Advisory Council on Migrant
Health; Cancellation of Meeting
Name: National Advisory Council on
Migrant Health.
Dates and Times: December 4, 2012,
8:30 a.m. to 5:00 p.m. December 5, 2012,
8:00 a.m. to 12:00 p.m.
STATUS: The meeting of the National
Advisory Council on Migrant Health,
scheduled for December 4 and 5, 2012,
is cancelled. This cancellation applies
to all sessions of the meeting. The
meeting was announced in the Federal
Register of November 8, 2012 (77 FR
67014).
FOR FURTHER INFORMATION CONTACT:
Gladys Cate, Office of Special
Population Health, Bureau of Primary
Health Care, Health Resources and
Services Administration, 5600 Fishers
Lane, Room 15–74, Rockville, Maryland
20857; telephone (301) 594–0367.
Dated: November 20, 2012.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2012–28699 Filed 11–26–12; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
U.S. patent applications listed below
may be obtained by writing to the
indicated licensing contact at the Office
of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
SUMMARY:
E:\FR\FM\27NON1.SGM
27NON1
]]>Agencies
[Federal Register Volume 77, Number 228 (Tuesday, November 27, 2012)]
[Notices]
[Page 70788]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-28699]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Advisory Council on Migrant Health; Cancellation of
Meeting
Name: National Advisory Council on Migrant Health.
Dates and Times: December 4, 2012, 8:30 a.m. to 5:00 p.m. December
5, 2012, 8:00 a.m. to 12:00 p.m.
STATUS: The meeting of the National Advisory Council on Migrant
Health, scheduled for December 4 and 5, 2012, is cancelled. This
cancellation applies to all sessions of the meeting. The meeting was
announced in the Federal Register of November 8, 2012 (77 FR 67014).
FOR FURTHER INFORMATION CONTACT: Gladys Cate, Office of Special
Population Health, Bureau of Primary Health Care, Health Resources and
Services Administration, 5600 Fishers Lane, Room 15-74, Rockville,
Maryland 20857; telephone (301) 594-0367.
Dated: November 20, 2012.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2012-28699 Filed 11-26-12; 8:45 am]
BILLING CODE 4165-15-P
